Connection

Edward Hogan to Spinal Cord

Back to Details
This is a "connection" page, showing publications Edward Hogan has written about Spinal Cord.
Edward Hogan
Connection Strength
0.905
Spinal Cord
  1. Immunohistochemical localization of kininogen in rat spinal cord and brain. Exp Neurol. 1999 Oct; 159(2):528-37.
    View in: PubMed
    Score: 0.149
  2. Role of calpain and its inhibitors in tissue degeneration and neuroprotection in spinal cord injury. Ann N Y Acad Sci. 1997 Oct 15; 825:120-7.
    View in: PubMed
    Score: 0.130
  3. Ca2+-mediated degradation of central nervous system (CNS) proteins: topographic and species variation. Metab Brain Dis. 1987 Jun; 2(2):117-26.
    View in: PubMed
    Score: 0.063
  4. Proteolysis in quaking mouse brain and spinal cord. Neurochem Res. 1986 Feb; 11(2):173-83.
    View in: PubMed
    Score: 0.058
  5. Tissue calcium levels in CaCl2-induced myelopathy. Neurosci Lett. 1984 Aug 31; 49(3):279-83.
    View in: PubMed
    Score: 0.052
  6. Inhibition of proteolysis by a cyclooxygenase inhibitor, indomethacin. Neurochem Res. 2000 Nov; 25(11):1509-15.
    View in: PubMed
    Score: 0.040
  7. Increased calpain expression is associated with apoptosis in rat spinal cord injury: calpain inhibitor provides neuroprotection. Neurochem Res. 2000 Oct; 25(9-10):1191-8.
    View in: PubMed
    Score: 0.040
  8. Role of calpain in spinal cord injury: effects of calpain and free radical inhibitors. Ann N Y Acad Sci. 1998 May 30; 844:131-7.
    View in: PubMed
    Score: 0.034
  9. New inhibitors of calpain prevent degradation of cytoskeletal and myelin proteins in spinal cord in vitro. J Neurosci Res. 1998 Jan 15; 51(2):218-22.
    View in: PubMed
    Score: 0.033
  10. Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury. Brain Res. 1997 Mar 28; 752(1-2):301-6.
    View in: PubMed
    Score: 0.031
  11. A new mechanism of methylprednisolone and other corticosteroids action demonstrated in vitro: inhibition of a proteinase (calpain) prevents myelin and cytoskeletal protein degradation. Brain Res. 1997 Feb 14; 748(1-2):205-10.
    View in: PubMed
    Score: 0.031
  12. Role of calpain in spinal cord injury: increased calpain immunoreactivity in rat spinal cord after impact trauma. Neurochem Res. 1996 Apr; 21(4):441-8.
    View in: PubMed
    Score: 0.029
  13. An x-ray diffraction study of central and peripheral myelination in Jimpy and Quaking mice. Brain Res. 1975 Mar 07; 85(3):517-21.
    View in: PubMed
    Score: 0.027
  14. A sensitive fluorometric method for measurement of vascular permeability in spinal cord injury. J Neurotrauma. 1991; 8(2):149-56.
    View in: PubMed
    Score: 0.020
  15. Temporal profile of thromboxane-prostacyclin imbalance in experimental spinal cord injury. J Neurol Sci. 1988 Jan; 83(1):55-62.
    View in: PubMed
    Score: 0.016
  16. Increased thromboxane level in experimental spinal cord injury. J Neurol Sci. 1986 Jul; 74(2-3):289-96.
    View in: PubMed
    Score: 0.015
  17. Proteolytic enzymes in experimental spinal cord injury. J Neurol Sci. 1986 May; 73(3):245-56.
    View in: PubMed
    Score: 0.015
  18. Spinal cord infarction occurring during insertion of aortic graft. Neurology. 1966 Jan; 16(1):67-74.
    View in: PubMed
    Score: 0.014
  19. Vascular permeability in experimental spinal cord injury. J Neurol Sci. 1985 Oct; 70(3):275-82.
    View in: PubMed
    Score: 0.014
  20. Calcium-stimulated proteolysis in myelin: evidence for a Ca2+-activated neutral proteinase associated with purified myelin of rat CNS. J Neurochem. 1985 Aug; 45(2):581-8.
    View in: PubMed
    Score: 0.014
  21. Ca2+-accumulation in experimental spinal cord trauma. Brain Res. 1981 May 04; 211(2):476-9.
    View in: PubMed
    Score: 0.010
  22. Calpain activity and expression increased in activated glial and inflammatory cells in penumbra of spinal cord injury lesion. J Neurosci Res. 2000 Jul 15; 61(2):146-50.
    View in: PubMed
    Score: 0.010
  23. Combined TUNEL and double immunofluorescent labeling for detection of apoptotic mononuclear phagocytes in autoimmune demyelinating disease. Brain Res Brain Res Protoc. 2000 Jul; 5(3):305-11.
    View in: PubMed
    Score: 0.010
  24. The effects of spinal cord trauma on myelin. J Neuropathol Exp Neurol. 1980 May; 39(3):232-44.
    View in: PubMed
    Score: 0.010
  25. Increased calpain expression in activated glial and inflammatory cells in experimental allergic encephalomyelitis. Proc Natl Acad Sci U S A. 1998 May 12; 95(10):5768-72.
    View in: PubMed
    Score: 0.008
  26. Role of calpain in spinal cord injury: increased mcalpain immunoreactivity in spinal cord after compression injury in the rat. Neurochem Int. 1995 Oct-Nov; 27(4-5):425-32.
    View in: PubMed
    Score: 0.007
  27. Kininogen and kinin in experimental spinal cord injury. J Neurochem. 1991 Sep; 57(3):975-80.
    View in: PubMed
    Score: 0.005
  28. Xanthine oxidase in experimental spinal cord injury. J Neurotrauma. 1991; 8(1):11-8.
    View in: PubMed
    Score: 0.005
  29. Leukotriene B4 release and polymorphonuclear cell infiltration in spinal cord injury. J Neurochem. 1990 Sep; 55(3):907-12.
    View in: PubMed
    Score: 0.005
  30. Changes in myelin and axonal proteins in CaCl2-induced myelopathy in rat spinal cord. Cent Nerv Syst Trauma. 1984; 1(2):131-7.
    View in: PubMed
    Score: 0.003
  31. A role for calcium and activation of neutral proteinase in myelinolysis? Prog Clin Biol Res. 1984; 146:145-52.
    View in: PubMed
    Score: 0.003
  32. Degradation of cytoskeletal proteins in experimental spinal cord injury. Neurochem Res. 1982 Dec; 7(12):1465-75.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.